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Abstract
L-Carnitine is used extensively in functional foods and food supplements; consequently, the control of its enantiomeric
purity is of paramount importance. A new derivatization procedure and chiral gas chromatographic method with flame
ionization detection, using a cyclodextrin based stationary phase, enables prompt, simple, and inexpensive screening of
the enantiomeric ratio of L- and D-carnitine in samples with different matrices. Conversion of carnitine to β-acetoxy-γ-
butyrolactone was optimized for maximum conversion (98% of the desired product lactone was formed and 2% of the
side product γ-crotonolactone) and minimum racemization (no changes at the chiral center were detected) and time con-
sumption. As it is shown in this study, a fast gas chromatographic method, with total run time of 7 min, together with the
new derivatization procedure enables an effective enantiomeric purity screening of L-carnitine in real samples such as
food supplements and L-carnitine raw ingredient. 
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1. Introduction
Carnitine (3-hydroxy-4-(trimethylazaniumyl)buta-
noate, 1) (Fig. 1) and its ester analogues are chiral com-
pounds that can play an important biochemical role and
possess properties which are beneficial to human
health.1–4 In fact, only R-enantiomer (L-carnitine) is signi-
ficant in the energy producing pathway; the S-enantiomer
(D-carnitine) is believed to be inactive and to even cause
inhibition of carnitine acetyl-transferase.5,6
The zwitterionic L-carnitine is non-volatile and is
biosynthesized from lysine and methionine. It facilitates
the transport of long-chained fatty acids from the cytosol
into the mitochondria, where the breakdown of fatty acids
and energy production occurs.7 Human genetic disorders
such as primary and secondary carnitine deficiencies lead
to disturbances in energy production and in the interme-
diary metabolism of the organism.8,9
Due to the increasing use of L-carnitine in functio-
nal foods and food supplements, monitoring of the enan-
tiomeric purity of L-carnitine in these products is essen-
tial. This also applies to the L-carnitine feedstock used in
food production. Consequently, a fast and inexpensive
analytical procedure is needed.
There are many high-performance liquid chromato-
graphic (HPLC)10–13 and capillary electrophoretic (CE)12–18
methods available for the separation of the enantiomeric L-
and D-carnitine; even 1H NMR methods using chiral shift
reagents have been utilized.19 These methods give good re-
sults but are tedious and require expensive chiral derivatiza-
tion reagents or chiral buffer selectors, which makes a rou-
tine analysis impractical. On the other hand, no simple gas
chromatographic (GC) methods exist for the screening of
L- and D-carnitine in real samples; this is probably due to
the non-volatility barrier of carnitine. In this regard, an effi-
cient transformation of this amino acid from non-volatile to
volatile form is crucial. Di Tullio et al. reported on the first
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and only gas chromatographic resolution of L- and D-carni-
tine, based on standards.20 The attempt to repeat this experi-
ment in our laboratory proved unfruitful. 
The aim of the present study was to develop a new
derivatization procedure and chiral GC method for the ra-
pid screening of the enantiomeric purity of L-carnitine in
various samples, irrespective of the sample matrix. The
derivatization procedure should also be useful for the GC
analysis of acylcarnitines.
2. Experimental
2. 1. Materials
Food supplement samples in capsules: L-carnitine
(Food Supplement 1 – FS1) was purchased from Goerlich
Pharma (Edling, Germany), L-karnitin 500 (FS2) from
Encian d.o.o. (Donji Stupnik, Croatia), ActivLab L-Carni-
tine Plus Green Tea (FS3) from Regis Ltd. (Krakow, Po-
land), and Liver Aid (FS4) from 4Life® (Farmington, CT,
USA). Raw ingredient samples: L-carnitine (Raw Ingre-
dient 1 – RI1) and L-carnitine tartrate (RI2) were purcha-
sed from Maypro (Shanghai, China), L-carnitine tartrates
(RI3 and RI4) from Lonza (Basel, Switzerland), and L-
carnitine (RI5) from Brenntag Chemicals Trading Co.
Ltd. (Shanghai, China).
2. 2. Chemicals and Standards
HPLC grade methanol (MeOH) was purchased from
Baker (Derenter, Netherlands), analytical grade acetyl
chloride from Merck (Darmstadt, Germany), analytical
grade pyridine from Carlo Erba Reagenti (Milano, Italy).
HPLC grade acetonitrile (MeCN), N,N-Diisopropylethy-
lamine (DIPEA) (>99%), dimethylformamide (DMF)
(>99.9%), A.C.S. Reagent grade dimethyl sulfoxide (DM-
SO) (99.9%), L- and D-carnitine (98%) were purchased
from Sigma-Aldrich (Steinheim, Germany). Pyridine was
distilled prior to use. Twice distilled water was used. 
2. 3. Sample Preparation Prior 
to Derivatization
No sample preparation was used for pure carnitine
(inner salt) samples RI1, RI5 (500 mg) and standards L-
and D-carnitine (80 mg). 
Sample preparation for RI2 – RI4. The sample
(500 mg) was dissolved in water (1 mL), filtered through
a 0.45 μm Millipore Millex-HV hydrophilic polyvinyli-
dene difluoride-PVDF membrane filter (Middlesex, MA,
USA) and concentrated to the point at which the sample
remained in solution.
In the case of food supplements, the contents of four
identical capsules were mixed and homogenized with a
pestle and mortar. Then, from this homogenized material,
the amount of sample was accurately weighed for each in-
dividual analysis (∼500 mg for FS1, FS2, and ∼700 mg for
FS3, FS4). DMSO (10 mL) was added to the sample, vorte-
xed for 30 s, and centrifuged for 4 min at 3600 rpm. Super-
natant was decanted and to the solid residue MeOH (1 mL)
and then H2O (1 mL) were added. The suspension was vor-
texed for 30 s, filtered through a 0.45 μm PVDF filter and
concentrated to the point at which the sample remained in
solution.
2. 4. Derivatization of Carnitine
To the prepared samples and standards DMF (2 mL)
and DIPEA (0.4 mL – only when analyzing RI2 – RI4 and
FS1 – FS4) were added and the suspension was refluxed for
1h; to simplify this step the cyclization of carnitine standard
was alternatively achieved under microwave radiation at
170 °C for 5 min in MeCN (1.5 mL). Volatile components
were subsequently evaporated under reduced pressure; the
remaining β-hydroxy-γ-butyrolactone was redissolved in
pyridine (2 mL) and filtered through a 0.45 μm PVDF filter.
Acetyl chloride (0.3 mL) was added drop wise to a solution
of the lactone in cold pyridine, and the solution was heated
to reflux and immediately cooled to room temperature. Me-
OH (2 mL) was added to the solution. A volume of 0.2 mL
was taken from the solution and all volatile components
were removed under reduced pressure to obtain β-acetoxy-
γ-butyrolactone. The solid residue was redissolved in Me-
OH (1 mL) without purification, filtered through a 0.45 μm
PVDF filter, and subjected to chiral GC analysis. In the ca-
se of the analysis of FS4 the sample subjected to GC was
concentrated 10-fold relative to the other samples. 
Microwave reactions were conducted using a focu-
sed microwave unit (Discover by CEM Corporation,
Matthews NC). The machine consists of a continuous, fo-
cused microwave power delivery system with an operator-
selectable power output from 0 to 300 W. Reactions were
performed in glass vessels (capacity 10 mL) sealed with a
septum. The mixtures were stirred with a Teflon-coated
magnetic stir bar in the vessel.
2. 5. GC-FID Analysis
GC-FID analyses were conducted on a VARIAN 3900
system (Varian, Palo Alto, CA, USA) using a fused-silica
capillary CP-Chirasil-Dex CB column (0.25 μm; 25 m ×
0.25 mm I.D., Varian). Conditions were as follows: carrier
gas (H2) at 1.5 mL/min; injection port T = 200 °C, FID T =
225 °C, 130 °C isotherm. The injection volume was 0.3 μL,
and split ratio 1:25. Galaxie Workstation software version
1.7.403.22 was used for the evaluation of the data collected.
3. Results and Discussion
Carnitine and its analogues are non-volatile com-
pounds and are soluble almost exclusively in protic sol-
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vents due to their zwitterionic nature. Volatility and solu-
bility of derivatized carnitine in organic solvents are, ho-
wever, enhanced; hence the amenability of carnitine to
GC analysis.
This report is focused on an innovative derivatiza-
tion procedure for carnitine (also applicable to acylcarniti-
nes) in GC analysis. Additionally, a fast chiral GC-FID
method, based on a cyclodextrin capillary column, was
developed, which enables the resolution of L- and D-car-
nitine. The new derivatization procedure combined with
chiral GC method permits the analysis of a large number
of samples in a limited amount of time.
3. 1. Derivatization Procedure and Chiral
GC-FID Method
Using our approach, little or no sample preparation
is required prior to derivatization of carnitine.
The derivatization process involves two steps (Fig. 1).
First, carnitine (1) cyclizes to give β-hydroxy-γ-but-
yrolactone (2); in cases where carnitine does not form an
inner salt, DIPEA was added. Secondly, the β-hydroxy-γ-
butyrolactone was acetylated with acetyl chloride to give
β-acetoxy-γ-butyrolactone (3). The second step should be
omitted when acylcarnitines are subjected to gas chroma-
tography, consequently even further simplifying the deri-
vatization.
With the introduction of microwave technology the
intramolecular cyclization of carnitine occurs signifi-
cantly more rapidly than similar known transformations.21
Fig. 1. Two-step derivatization procedure for L- and D-carnitine.
Fig. 2. GC-FID separation of (R) and (S)-β-acetoxy-γ-butyrolactone. Chromatographic conditions are given in the experimental section.
The second step is at least comparable in speed and effi-
ciency to other state-of-the-art acylations.22 The acetyla-
tion step was done merely to drastically improve peak
shape, and consequently resolution, and to substantially
shorten the retention times of L- and D-carnitine to ∼6 mi-
nutes when applied to chiral GC analysis. 
The transformation of carnitine to β-acetoxy-γ-but-
yrolactone was carefully conducted to maximize the ove-
rall conversion, minimize by-product formation and to
make it as rapid as possible. In the first step, 98% β-hy-
droxy-γ-butyrolactone was formed but also 2% γ-crotono-
lactone, which did not interfere in the subsequent trans-
formations and analyses. In the second step, β-hydroxy-γ-
butyrolactone (2) was fully transformed into β-acetoxy-γ-
butyrolactone (3). Furthermore, the chiral centre in the
carnitine molecule was not affected and consequently no
sign of racemization was observed after either of the two
derivatization steps. The excellent overall yield underlies
the good sensitivity of the chiral GC method.
In the first (and only) report of the gas chromatograp-
hic resolution of L- and D-carnitine standards, Di Tullio et
al. converted D- or L-carnitine, respectively, to the corres-
ponding β-hydroxy-γ-butyrolactones which were separated
in 20 min using a β-cyclodextrin stationary phase column
that differed from the one we used.20 It should be stressed
that we made every endeavour to repeat these experiments
but were unable to achieve reported results. Firstly, a prob-
lem with solubility of carnitine in nitromethane, the injec-
tion solvent for GC, was encountered. And secondly, a con-
siderable amount of side products formed in the injector
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port at 200 °C where the cyclization of carnitine takes pla-
ce, and this greatly reduces the sensitivity of the method.
The array of side products may result from different GC in-
jector types, which detrimentally affects the wide applicabi-
lity of this method. The aforementioned work was done on
standards; however, real sample matrices often include ad-
ditional compounds which may even further complicate the
analysis. We overcame these problems with our two step
pre-chromatographic derivatization described above. In ad-
dition, the new GC method enables baseline resolution of
carnitine enantiomers in under 7 min (Fig. 2).
3. 2. Enantiomeric Purity Screening 
of L-carnitine in Real Samples
The new derivatization procedure/chiral GC method
for screening of enantiomeric purity of L-carnitine was te-
sted on five raw ingredient samples and four different
food supplement samples with different matrices, giving
the results shown in Table 1. The quantitation limit for L-
and D-carnitine was determined at 2mg/g (S/N ≥ 10).
In this study we developed a fast chiral GC method
for baseline enantiomeric resolution of L- and D-carniti-
ne using a cyclodextrin-based capillary column, with
prior derivatization for enhanced volatility and solubility
of carnitine in organic solvents. No racemization was
observed during the derivatization process. The enantio-
meric composition of L- and D-carnitine was determined
as the enantiomeric composition of the β-acetoxy-γ-but-
yrolactones.
This new derivatization procedure, together with the
newly developed GC method excels in simplicity, applica-
bility, and minimal sample loss (maximum conversion).
The total analysis time is greatly shortened in comparison
to other enantiomeric determinations of L- and D-carniti-
ne and the overall analysis is relatively inexpensive. The
general applicability of the method was demonstrated by
screening the enantiomeric purity of L-carnitine in four
food supplements and five raw ingredients.
The future work will be directed towards the quanti-
fication of L-carnitine. The chemical properties of D-car-
nitine are identical to those of L-carnitine and this should
make the use of the former, as an internal standard, ideal
for the determination of L-carnitine in various samples,
where side reactions and other interferences are possible
during the derivatization process and GC analysis.
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Povzetek
L-karnitin se intenzivno uporablja v obliki funkcionalnih `ivil in prehranskih dopolnil, zato je nadzor njegove enantio-
merne ~istote izjemnega pomena. V ta namen smo razvili nov derivatizacijski postopek in kiralno plinsko kromatograf-
sko metodo s plamensko ionizacijsko detekcijo, pri ~emer smo uporabili ciklodekstrinsko stacionarno fazo. Ta kombi-
nacija omogo~a hitro, enostavno in poceni kontrolo enantiomernega razmerja L- in D-karnitina v vzorcih z razli~nimi
matriksi. Pretvorbo karnitina v β-acetoksi-γ-butirolakton smo optimizirali z namenom maksimalne konverzije (nastalo
je 98 % `elenega laktonskega produkta in 2% stranskega produkta γ-krotonolaktona) ter minimalne racemizacije (na ki-
ralnem centru ni bilo sprememb) in porabe ~asa. Pokazali smo, da nova plinska kromatografska metoda, s ~asom anali-
ze 7 minut, v povezavi z novim derivatizacijskim postopkom omogo~a u~inkovito kontrolo enantiomerne ~istote L-kar-
nitina v realnih vzorcih kot so prehranska dopolnila in vhodne surovine.
